LifeStance Health Group, Inc. (NASDAQ:LFST) Shares Bought by Vanguard Group Inc.

featured-image

Vanguard Group Inc. increased its position in LifeStance Health Group, Inc. (NASDAQ:LFST – Free Report) by 7.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,689,396 shares of the company’s stock after acquiring an additional 784,818 shares during the [...]

Vanguard Group Inc. increased its position in LifeStance Health Group, Inc. ( NASDAQ:LFST – Free Report ) by 7.

9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,689,396 shares of the company’s stock after acquiring an additional 784,818 shares during the period. Vanguard Group Inc.



’s holdings in LifeStance Health Group were worth $78,781,000 as of its most recent SEC filing. Other hedge funds have also recently bought and sold shares of the company. Blue Trust Inc.

boosted its position in LifeStance Health Group by 124.4% during the fourth quarter. Blue Trust Inc.

now owns 3,828 shares of the company’s stock worth $27,000 after purchasing an additional 2,122 shares in the last quarter. R Squared Ltd purchased a new stake in shares of LifeStance Health Group in the 4th quarter worth about $80,000. Cibc World Markets Corp acquired a new stake in LifeStance Health Group in the 4th quarter valued at about $96,000.

Handelsbanken Fonder AB purchased a new position in LifeStance Health Group during the 4th quarter valued at about $128,000. Finally, Versor Investments LP acquired a new position in LifeStance Health Group during the fourth quarter worth about $131,000. 85.

50% of the stock is owned by hedge funds and other institutional investors. Wall Street Analysts Forecast Growth A number of brokerages have recently weighed in on LFST. KeyCorp initiated coverage on shares of LifeStance Health Group in a research note on Tuesday.

They set an “overweight” rating and a $9.00 price objective for the company. The Goldman Sachs Group raised LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.

00 price target for the company in a research report on Monday, December 16th. William Blair restated an “outperform” rating on shares of LifeStance Health Group in a research report on Friday, February 28th. Finally, Canaccord Genuity Group assumed coverage on LifeStance Health Group in a research report on Thursday, April 3rd.

They set a “buy” rating and a $8.00 price objective for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock.

According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $8.58. Insider Buying and Selling at LifeStance Health Group In related news, insider Lisa K.

Miller sold 18,845 shares of the business’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.

50. Following the completion of the sale, the insider now directly owns 339,810 shares in the company, valued at approximately $2,344,689. The trade was a 5.

25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website . 6.

60% of the stock is owned by company insiders. LifeStance Health Group Price Performance Shares of NASDAQ:LFST opened at $6.77 on Friday.

The company has a market cap of $2.60 billion, a P/E ratio of -26.04 and a beta of 1.

30. The business has a fifty day simple moving average of $7.30 and a 200-day simple moving average of $7.

33. LifeStance Health Group, Inc. has a 52 week low of $4.

64 and a 52 week high of $8.61. The company has a quick ratio of 1.

32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19.

LifeStance Health Group Company Profile ( Free Report ) LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. Recommended Stories Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. ( NASDAQ:LFST – Free Report ). Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.

com's FREE daily email newsletter ..